Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Arcor exchange offer
The company issued new notes due 2027
Toyota Motor Credit $1.35 billion notes offering
We advised the company on the SEC-registered notes offering
Bank of America $1.5 billion cash tender offer for preferred stock
We represented BofAS in connection with 14 concurrent tender offers
Bank of America $2 billion equality progress sustainability bond offering
The investment-grade notes are due 2028
NatWest Group $1.5 billion senior notes offering
We advised NatWest Group on the SEC-registered offering
Roivant Sciences $150 million equity offering
We advised the company on its debut SEC-registered primary and secondary offering
Akoya Biosciences $50 million at-the-market program
The common stock is listed on the Nasdaq Global Select Market
Lucid $600 million at-the-market offering and $915 million additional investment
The common stock is listed on Nasdaq
QUALCOMM $1.9 billion notes offering
The investment-grade notes are due 2033 and 2053
Comcast $2.5 billion notes offering
We advised Comcast on the investment-grade debt offering